Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212199 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Brief Counseling for Weight Management
A Phase 4 study of 1. Obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 4
- Development phase
- 246
- Enrollment target
- 1
- Study location
NCT00212199: Completed Phase 4 study of 1. Obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00212199 is a Phase 4 study of 1. Obesity that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 246 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00212199, a Phase 4 study of 1. Obesity, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 246 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.
Conditions Studied
Interventions
- DRUG orlistat
- BEHAVIORAL Brief cognitive behavioral counseling
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
What the finished NCT00212199 record still lists
NCT00212199 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower).
The record links to 1 condition, with 1. Obesity appearing as the primary indexed condition, and to 2 interventions - of which orlistat is the first listed.
NCT00212199 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00212199 about?
NCT00212199 is a clinical study titled "Effectiveness of Brief Counseling for Weight Management". The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.
What is the current status of trial NCT00212199?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 246 participants. The study started on 2002-01. Estimated completion is 2004-08.
What conditions does trial NCT00212199 study?
This clinical trial studies the following conditions: 1. Obesity.
What interventions are being tested in trial NCT00212199?
The interventions under investigation include: orlistat (DRUG), Brief cognitive behavioral counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00212199?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00212199 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00212199's enrollment target sits among peer trials
246 356th of 2000 higher than 1,644 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia